HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thamer H Albekairi Selected Research

Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)

10/2023Histamine H4 Receptor Antagonist Ameliorates the Progression of Experimental Autoimmune Encephalomyelitis via Regulation of T-Cell Imbalance.
5/2023DAPTA, a C-C Chemokine Receptor 5 (CCR5), Leads to the Downregulation of Notch/NF-κB Signaling and Proinflammatory Mediators in CD40+ Cells in Experimental Autoimmune Encephalomyelitis Model in SJL/J Mice.
1/2022CCR1 antagonist ameliorates experimental autoimmune encephalomyelitis by inhibition of Th9/Th22-related markers in the brain and periphery.
1/2022Cathepsin B inhibitor alleviates Th1, Th17, and Th22 transcription factor signaling dysregulation in experimental autoimmune encephalomyelitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thamer H Albekairi Research Topics

Disease

4Infections
01/2024 - 04/2022
4Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2023 - 01/2022
4Autistic Disorder (Autism)
01/2022 - 02/2021
4Ischemic Stroke
11/2021 - 11/2018
3Inflammation (Inflammations)
01/2024 - 08/2020
3Stroke (Strokes)
11/2021 - 11/2018
2Ulcer
01/2024 - 01/2024
2Pain (Aches)
01/2024 - 11/2021
2Wounds and Injuries (Trauma)
12/2023 - 08/2020
1Post-Acute COVID-19 Syndrome
03/2024
1Rheumatoid Arthritis
01/2024
1Bites and Stings (Sting)
01/2024
1Hypersensitivity (Allergy)
01/2024
1MELAS Syndrome (Syndrome, MELAS)
01/2024
1Meningoencephalitis
01/2024
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2024
1Body Weight (Weight, Body)
01/2024
1Ulcerative Colitis
01/2024
1Abscess
01/2024
1Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)
01/2024
1Pneumonia (Pneumonitis)
12/2023
1Cognitive Dysfunction
12/2023
1Tremor (Tremors)
12/2023
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2023
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
11/2023
1Fibrosis (Cirrhosis)
11/2023
1Neurodevelopmental Disorders
03/2023
1Cardiotoxicity
01/2023
1Cardiovascular Diseases (Cardiovascular Disease)
01/2023
1Myocardial Infarction
01/2023
1Nervous System Diseases (Neurological Disorders)
11/2022
1Huntington Disease (Huntington's Disease)
11/2022
1Whipple Disease (Whipple's Disease)
04/2022
1Parkinson Disease (Parkinson's Disease)
04/2022
1Memory Disorders (Memory Loss)
01/2022
1Demyelinating Diseases (Demyelinating Disease)
01/2022
1Reperfusion Injury
11/2021

Drug/Important Bio-Agent (IBA)

4VaccinesIBA
01/2024 - 04/2022
3PhytochemicalsIBA
01/2024 - 11/2022
2EpitopesIBA
01/2024 - 12/2023
2AntioxidantsIBA
01/2024 - 02/2021
2Messenger RNA (mRNA)IBA
01/2024 - 12/2023
2Heavy MetalsIBA
11/2023 - 03/2023
2Peptides (Polypeptides)IBA
04/2022 - 09/2019
2Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2022
2Glutamic Acid (Glutamate)FDA Link
11/2021 - 01/2019
2Opioid Receptors (Opioid Receptor)IBA
11/2021 - 09/2019
2biphalinIBA
11/2021 - 09/2019
2Glucose (Dextrose)FDA LinkGeneric
01/2019 - 11/2018
1Flurbiprofen (Froben)FDA LinkGeneric
01/2024
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2024
1AntigensIBA
01/2024
1SolutionsIBA
01/2024
1beta Lactam AntibioticsIBA
01/2024
1Biomarkers (Surrogate Marker)IBA
01/2024
1SmokeIBA
01/2024
1QuercetinIBA
01/2024
1PolymersIBA
01/2024
1Mesalamine (Mesalazine)FDA LinkGeneric
01/2024
1ProteomeIBA
12/2023
1Cadmium Chloride (Cadmium Dichloride)IBA
12/2023
1Silver Sulfadiazine (SSD)FDA LinkGeneric
12/2023
1Letrozole (Femara)FDA LinkGeneric
11/2023
1Histamine H4 ReceptorsIBA
10/2023
1JNJ 10191584IBA
10/2023
1D-Ala-peptide T-amideIBA
05/2023
1CC ChemokinesIBA
05/2023
1Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2023
1Antihypertensive Agents (Antihypertensives)IBA
01/2023
13-nitropropionic acidIBA
11/2022
1boswellic acidIBA
11/2022
1Anti-Bacterial Agents (Antibiotics)IBA
04/2022
1Tetracycline (Achromycin)FDA LinkGeneric
04/2022
1beta-LactamsIBA
04/2022
1tofacitinibIBA
04/2022
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
04/2022
1Janus Kinase InhibitorsIBA
04/2022
1methylmercuric chlorideIBA
01/2022
1N- (3- propylcarbamoyloxirane- 2- carbonyl)- isoleucyl- prolineIBA
01/2022
1SB-332235IBA
01/2022
1Chemokine ReceptorsIBA
01/2022
1UCB 35625IBA
01/2022
1Cathepsin BIBA
01/2022
1Neuroprotective AgentsIBA
11/2021
1Opioid Analgesics (Opioids)IBA
11/2021
1NociceptinIBA
11/2021
1Excitatory Amino AcidsIBA
11/2021
15-aminoisoquinolinoneIBA
02/2021
1Interleukin-9 (Interleukin 9)IBA
02/2021
1Interleukin-10 (Interleukin 10)IBA
02/2021
1Therapeutic UsesIBA
02/2021
1Interleukin-17 (Interleukin 17)IBA
02/2021
1Environmental Pollutants (Pollutants, Environmental)IBA
02/2021
1Lipid PeroxidesIBA
02/2021
1NADPH Oxidases (NAD(P)H oxidase)IBA
02/2021
1Diethylhexyl Phthalate (DEHP)IBA
02/2021
1Oxidants (Oxidizing Agents)IBA
02/2021

Therapy/Procedure

2Therapeutics
03/2024 - 01/2022
1Immunotherapy
01/2024
1Bandages (Bandage)
12/2023